ng-nitroarginine methyl ester has been researched along with Pleural Effusion, Malignant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lala, PK; Orucevic, A | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Pleural Effusion, Malignant
Article | Year |
---|---|
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Combined Modality Therapy; Female; Immunotherapy; Interleukin-2; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pleural Effusion, Malignant; Pulmonary Edema; Statistics, Nonparametric; Tumor Cells, Cultured | 1996 |